Escherichia coli, a Versatile Pathogen (Record no. 9669)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 04022nam a22003017a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240305192631.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 230111b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9783319996646 |
International Standard Book Number | 3319996649 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | DLC |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Gad Frankel |
9 (RLIN) | 26356 |
222 ## - KEY TITLE | |
Key title | Common terms and phrases |
Qualifying information | actin activation adherence adhesin AggR antibiotic resistance antigens Antimicrob Agents Chemother apoptosis bacterial beta-lactamases binding biofilm carbapenemase cause chromosome Clin Microbiol clinical clone coli isolates colistin colonization detection diarrhea disease EAEC strain EHEC EIEC encoded enteroaggregative Escherichia coli Enterobacteriaceae enteropathogenic Escherichia coli enzymes EPEC epithelial cells ESBL Escherichia coli Escherichia coli O104:H4 Escherichia coli O157:H7 Escherichia coli strains ETEC ETT2 ExPEC extraintestinal fimbriae flexneri Frankel G genome global GTPases hemolytic uremic syndrome host cell human induce Infect Immun inflammasome Inhibition interaction intestinal Klebsiella pneumoniae membrane Mol Microbiol molecular mucosal Nataro JP NF-jB NF-kB outbreak strain pathogenesis pathogenic Escherichia coli pathotypes pathway patients plasmid PLoS protease protein receptor regulation rodentium role secretion system sequence type serotype Shiga toxin Shigella signalling small GTPases ST131 isolates studies Stx2 subunit syndrome T3SS effectors target toxin-producing Escherichia coli translocation type III secretion vaccine virulence factors virulence genes vitro vivo Wang Zhang |
245 ## - TITLE STATEMENT | |
Title | Escherichia coli, a Versatile Pathogen |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | London: |
Name of publisher, distributor, etc. | Springer, |
Date of publication, distribution, etc. | 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 242 pages |
490 ## - SERIES STATEMENT | |
Volume/sequential designation | Volume 416 of Current Topics in Microbiology and Immunology |
505 ## - FORMATTED CONTENTS NOTE | |
Formatted contents note | Contents:<br/><br/>Enteroaggregative Escherichia coli<br/><br/> <br/> The Type III Secretion System of Pathogenic Escherichia coli<br/><br/> <br/>Modulation of Host Cell Processes by T3SS Effectors<br/><br/> <br/>H4 OutbreakThe Danger Is Still Out There<br/><br/> <br/>Extraintestinal Pathogenic Escherichia coli<br/> <br/> <br/>Evolution and Emergence of DrugResistant Pathogens<br/><br/> <br/>Current Trends in Antimicrobial Resistance of Escherichia coli<br/><br/> <br/> Vaccines Against Escherichia coli<br/><br/> <br/><br/> <br/> |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Escherichia coli is a facultative anaerobic Gamma-proteobacterium, which belongs to the family Enterobacteriaceae. While being an important constituent of the normal gut microbiota, specialized E. coli clones have acquired genetic elements that allow them to compete with the endogenous commensals, colonise normally sterile niches and cause disease. E. coli pathotypes can cause intestinal and extra intestinal infections (e.g. UTI, sepsis) and associate with mammalian cells while being extra- or intra-cellular. In recent years, E. coli infections have become a serious clinical problem, due to the rapid spread of antibiotic resistance. Thus, infections with intestinal E. coli (e.g. E. coli O104) or extraintestinal pathogenic strains (e.g. E. coli ST131) are becoming difficult to treat and are often lethal. Consequently, there is a pressing need to develop alternative control measures, including the identification of new drug targets and development of vaccines that offer lasting protection.<br/><br/>This volume focuses on several types of E. coli infections (intestinal and extraintestinal), virulence factors, and E. coli pandemics. It addresses the problem of antibiotic resistance, and a dedicated chapter discusses the need to develop alternative control measures. Given its depth and breadth of coverage, the book will benefit all those interested in the biology, genetics, physiology and pathogenesis of E. coli, and in related vaccine development. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
General subdivision | Science / Life Sciences / Bacteriology |
9 (RLIN) | 47942 |
General subdivision | Medical / Microbiology |
9 (RLIN) | 27394 |
General subdivision | Medical / Infectious Diseases |
9 (RLIN) | 27009 |
General subdivision | Medical / General |
9 (RLIN) | 26821 |
General subdivision | Science › Life Sciences › Bacteriology |
9 (RLIN) | 47837 |
700 ## - ADDED ENTRY--PERSONAL NAME | |
9 (RLIN) | 26357 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | ddc |
Koha item type | E-BOOKS |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 01/11/2023 | EBS13717 | 01/11/2023 | EBS13717 | 01/11/2023 | E-BOOKS |